Terbuthylazine

Terbuthylazine

SCHEMBL367486

CC(N)=O.CCNc1nc(Cl)nc(NC(C)(C)C)n1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.60
LMNA P02545 5/20 0.60
ALDH1A1 P00352 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.58
PDE4A P27815 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C19 P33261 1/20 0.51
MEN1 O00255 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CREBBP Q92793 1/20 0.46
GAA P10253 3/20 0.45
MCL1 Q07820 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Terbuthylazine SCHEMBL9715292 0.89 KMT2A (0.74) KMT2ALMNAALDH1A1SMN1; SMN2PDE4A
Terbuthylazine SCHEMBL8539245 0.89 KMT2A (0.74) KMT2ALMNAALDH1A1SMN1; SMN2PDE4A
Terbuthylazine SCHEMBL23642 0.89 KMT2A (0.74) KMT2ALMNAALDH1A1SMN1; SMN2PDE4A
Terbuthylazine SCHEMBL27492098 0.87 KMT2A (0.72) KMT2ALMNAALDH1A1SMN1; SMN2PDE4A
Terbuthylazine SCHEMBL9586446 0.86 KMT2A (0.62) KMT2ALMNAALDH1A1SMN1; SMN2PDE4A
Terbuthylazine SCHEMBL27458672 0.81 KMT2A (0.64) KMT2ALMNAALDH1A1SMN1; SMN2PDE4A
Stearic Acid SCHEMBL1665512 0.80 KMT2A (0.55) KMT2ALMNAALDH1A1SMN1; SMN2PDE4A
SCHEMBL19687642 0.80 LMNA (0.68) KMT2ALMNAALDH1A1SMN1; SMN2PDE4A
SCHEMBL27368205 0.79 LMNA (0.68) KMT2ALMNAALDH1A1SMN1; SMN2PDE4A
Simazine SCHEMBL8197401 0.79 LMNA (0.68) KMT2ALMNAALDH1A1PDE4ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1531670-B1 HERBICIDAL COMPOSITION SYNGENTA PARTICIPATIONS AG (CH) 2015-12-09 EP disclosed
US-8097561-B2 Herbicidal composition SYNGENTA CROP PROTECTION, INC. (US) 2012-01-17 US disclosed
EP-1531670-A4 HERBICIDAL COMPOSITION SYNGENTA PARTICIPATIONS AG (CH) 2005-11-23 EP disclosed
US-20050233907-A1 Herbicidal composition SYNGENTA CROP PROTECTION AG (CH) 2005-10-20 US disclosed
EP-1531670-A1 HERBICIDAL COMPOSITION Syngenta Participations AG (CH) 2005-05-25 EP disclosed
WO-2003105587-A1 HERBICIDAL COMPOSITION SYNGENTA PARTICIPATIONS AG (CH) 2003-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050233907-A1 Herbicidal composition ADH5, ADH1C, AQP3 KMT2A 1324/4885LMNA 3158/4885ALDH1A1 81/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.